Statement of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Cash flows from operating activities:
Net loss attributable to common shareholders	$ 1,282,103	$ 2,503,755
Adjustments to reconcile net loss to net cash used in operating activities
Amortization (accretion) of investments	(778,138)	(3,119,078)
Realized investment gains, net	(3,412,233)	(2,903,906)
Unrealized trading (gains) losses included in income	(14,539)	947,630
Realized trading (gains) losses included in income	0	(387,750)
Amortization of deferred policy acquisition costs	0	0
Amortization of cost of insurance acquired	218,246	226,901
Depreciation	141,702	200,450
Net income attributable to noncontrolling interest	(94,567)	235,838
Charges for mortality and administration of universal life and annuity products	(1,107,778)	(1,665,654)
Interest credited to account balances	867,663	1,385,988
Change in accrued investment income	(112,756)	72,527
Change in reinsurance receivables	17,052	(95,660)
Change in policy liabilities and accruals	(577,674)	(589,949)
Change in income taxes receivable (payable)	688,603	(2,013,216)
Change in other assets and liabilities, net	(3,135,372)	(1,412,184)
Net cash used in operating activities	(6,017,688)	(6,614,308)
Proceeds from investments sold and matured:
Fixed maturities available for sale	6,102,950	3,009,394
Equity securities available for sale	438,111	1,141,660
Trading securities	0	16,893
Mortgage loans	1,801,132	6,093,597
Discounted mortgage loans	0	0
Real estate	4,053,937	9,230,904
Payments to Acquire Notes Receivable	2,499,998	0
Policy loans	636,556	686,113
Short term investment	0	228,503
Total proceeds from investments sold and matured	15,532,684	20,407,064
Cost of investments acquired:
Fixed maturities available for sale	(3,955,081)	(3,557,854)
Equity securities available for sale	(505,516)	(2,432,839)
Trading securities	0	0
Mortgage loans	(12,365)	(9,638)
Discounted mortgage loans	0	0
Real estate	(3,526,736)	(6,828,846)
Policy loans	(565,345)	(487,040)
Short-term investments	0	(16,579)
Total cost of investments acquired	(8,565,043)	(13,332,796)
Sale of property and equipment	0	0
Net cash provided by investing activities	6,967,641	7,074,268
Cash flows from financing activities:
Proceeds From Policyholder Contract Deposits	772,689	1,459,335
Policyholder contract withdrawals	(594,960)	(1,389,465)
Proceeds from notes payable/line of credit	0	0
Payments of principal on notes payable/line of credit	0	0
Purchase of treasury stock	(403,637)	150,513
Non-controlling distributions of consolidated subsidiary	(82,265)	(498,889)
Sale of block of business	0	0
Net cash provided by (used in) financing activities	(308,173)	(278,506)
Net increase (decrease) in cash and cash equivalents	641,780	181,454
Cash and cash equivalents at beginning of period	11,822,615	13,977,443
Cash and cash equivalents at end of period	$ 12,464,395	$ 14,158,897